$NDAQ

Smith Bryan Everard sold $261K of NDAQ

Smith Bryan Everard (EVP, CPO) sold 3,000 shares of NASDAQ, INC. (NDAQ) at $86.91 ($0.26M total) on 2026-06-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Smith Bryan Everard
Published Jun 15, 2026, 8:08 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 15, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NDAQ
Neutral
high confidence
Mentioned
$NDAQ
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NDAQNeutralLow
01

Why it matters

The newest concrete fact is the disclosed open-market sale amount, price, and post-transaction holdings, with a stated pre-arranged 10b5-1 plan.

02

Market read

Traders may note the insider sale for sentiment, but the 10b5-1 framing and lack of fundamental catalysts make it low-impact.

03

What to watch

The article provides only the sale details; it does not include context like option exercises, tax events, or whether other insiders are selling/buying concurrently.

Relevance 3/10Novelty 5/10Timing: Filed 2026-06-15; transaction dated 2026-06-11.

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for NASDAQ, Inc. (NDAQ).

Company-level read

Ticker impact

$NDAQNeutralHigh confidence
Context

SEC Form 4 shows NDAQ EVP/CPO Smith Bryan Everard sold 3,000 shares at $86.91 on 2026-06-11 under a 10b5-1 plan.

Expected impact

Likely minimal near-term impact; any effect should be short-lived unless accompanied by other news.

Evidence & confidence

The filing is a Form 4 insider transaction with an explicitly pre-arranged 10b5-1 plan and no accompanying operational/regulatory catalyst in the text.

Market effects

No sector read-through; this is company-specific insider liquidity disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still be interpreted by some traders as reduced confidence, especially if it clusters around market stress.

Key entities

  • NASDAQ, Inc.

    Subject of the Form 4 insider transaction; EVP/CPO Smith Bryan Everard sold shares.

  • Smith Bryan Everard

    EVP, CPO who executed the reported sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NDAQMedAI 8/10

Nasdaq Invests $100 Million in Kraken’s Parent Company to Develop Tokenized Stocks

Nasdaq is investing $100 million in Payward, Kraken's parent company, to collaborate on tokenized stocks, 24/7 trading, and blockchain integration. The Nasdaq Equity Tokens (NETs) system aims to create digital representations of traditional stocks. The London Stock Exchange Group also partnered with Payward to tokenize its 100 largest companies. According to Reuters Breakingviews, the global market for tokenized shares is currently small but growing.

$NDAQMedAI 8/10

Wall Street’s Tokenized Stock Rush Is Getting Messy

Nasdaq and LSEG are investing in tokenized stocks, with Nasdaq committing $100M to Kraken's parent company. Experts discuss challenges in liquidity, privacy, and compliance for institutional adoption. AMC's tokenization controversy highlights ownership issues. RWA.xyz reports $2.91B in tokenized stocks and $13.31B in monthly transfer volume, but growth is uneven.

$NDAQMedAI 8/10

Nasdaq Invests $100 Million in Kraken Parent Payward

Nasdaq invested $100 million in Payward, Kraken's parent company, to advance tokenized market infrastructure. The partnership includes the Nasdaq Equity Token (NET) framework, set to launch in Q2 2027, and a market surveillance agreement. Nasdaq and Payward aim to improve capital and asset movement across the financial system, according to the companies.